Mendelson N. Daniel's most recent trade in Champions Oncology Inc was a trade of 21,590 Option to purchase Common Stock done . Disclosure was reported to the exchange on Nov. 12, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Champions Oncology Inc | Daniel N. Mendelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2024 | 21,590 | 21,590 | - | - | Option to purchase Common Stock | |
| Champions Oncology Inc | N. Mendelson Daniel | Director | Purchase of securities on an exchange or from another person at price $ 6.50 per share. | 12 Jan 2024 | 1,000 | 198,625 (1%) | 0% | 6.5 | 6,500 | Common Stock |
| Champions Oncology Inc | Daniel N. Mendelson | Director | Purchase of securities on an exchange or from another person at price $ 6.27 per share. | 11 Jan 2024 | 2,000 | 197,625 (1%) | 0% | 6.3 | 12,540 | Common Stock |
| Champions Oncology Inc | N. Daniel Mendelson | Director | Purchase of securities on an exchange or from another person at price $ 6.31 per share. | 10 Jan 2024 | 2,944 | 195,625 (1%) | 0% | 6.3 | 18,577 | Common Stock |
| Champions Oncology Inc | Mendelson Daniel N. | Director | Purchase of securities on an exchange or from another person at price $ 6.25 per share. | 09 Jan 2024 | 3,000 | 192,681 (1%) | 0% | 6.3 | 18,750 | Common Stock |
| Champions Oncology Inc | Mendelson Daniel N. | Director | Purchase of securities on an exchange or from another person at price $ 6.15 per share. | 08 Jan 2024 | 1,000 | 189,681 (1%) | 0% | 6.2 | 6,150 | Common Stock |
| Champions Oncology Inc | Daniel N. Mendelson | Director | Purchase of securities on an exchange or from another person at price $ 6.09 per share. | 05 Jan 2024 | 2,000 | 188,681 (1%) | 0% | 6.1 | 12,180 | Common Stock |
| Champions Oncology Inc | Mendelson Daniel N. | Director | Purchase of securities on an exchange or from another person at price $ 6.12 per share. | 04 Jan 2024 | 3,000 | 186,681 (1%) | 0% | 6.1 | 18,360 | Common Stock |
| Champions Oncology Inc | Daniel Mendelson N. | Director | Purchase of securities on an exchange or from another person at price $ 5.83 per share. | 03 Jan 2024 | 500 | 183,681 (1%) | 0% | 5.8 | 2,915 | Common Stock |
| Champions Oncology Inc | Mendelson Daniel N. | Director | Purchase of securities on an exchange or from another person at price $ 4.92 per share. | 21 Dec 2023 | 2,500 | 183,181 (1%) | 0% | 4.9 | 12,300 | Common Stock |
| Champions Oncology Inc | Mendelson N. Daniel | Director | Purchase of securities on an exchange or from another person at price $ 4.82 per share. | 20 Dec 2023 | 2,100 | 180,681 (1%) | 0% | 4.8 | 10,122 | Common Stock |
| Champions Oncology Inc | Daniel Mendelson N. | Director | Purchase of securities on an exchange or from another person at price $ 4.75 per share. | 19 Dec 2023 | 5,000 | 178,581 (1%) | 0% | 4.8 | 23,750 | Common Stock |
| Champions Oncology Inc | Daniel N. Mendelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2023 | 26,220 | 26,220 | - | - | Option to purchase Common Stock | |
| Champions Oncology Inc | Daniel N. Mendelson | Director | Purchase of securities on an exchange or from another person at price $ 6.40 per share. | 11 Oct 2023 | 5,000 | 163,081 (1%) | 0% | 6.4 | 32,000 | Common Stock |
| Champions Oncology Inc | Daniel N. Mendelson | Director | Purchase of securities on an exchange or from another person at price $ 6.41 per share. | 10 Oct 2023 | 1,100 | 158,081 (1%) | 0% | 6.4 | 7,051 | Common Stock |
| Champions Oncology Inc | Daniel N. Mendelson | Director | Purchase of securities on an exchange or from another person at price $ 6.48 per share. | 06 Oct 2023 | 1,530 | 156,981 (1%) | 0% | 6.5 | 9,914 | Common Stock |
| Champions Oncology Inc | Daniel N. Mendelson | Director | Purchase of securities on an exchange or from another person at price $ 6.47 per share. | 05 Oct 2023 | 2,000 | 155,451 (1%) | 0% | 6.5 | 12,940 | Common Stock |
| Champions Oncology Inc | Daniel N. Mendelson | Director | Purchase of securities on an exchange or from another person at price $ 6.40 per share. | 04 Oct 2023 | 5,000 | 153,451 (1%) | 0% | 6.4 | 32,000 | Common Stock |
| Champions Oncology Inc | Daniel N. Mendelson | Director | Purchase of securities on an exchange or from another person at price $ 6.30 per share. | 03 Oct 2023 | 2,500 | 148,451 (1%) | 0% | 6.3 | 15,750 | Common Stock |
| Champions Oncology Inc | Daniel N. Mendelson | Director | Purchase of securities on an exchange or from another person at price $ 6.16 per share. | 29 Sep 2023 | 4,000 | 173,581 (1%) | 0% | 6.2 | 24,640 | Common Stock |
| Champions Oncology Inc | Daniel N. Mendelson | Director | Purchase of securities on an exchange or from another person at price $ 6.22 per share. | 28 Sep 2023 | 5,000 | 169,581 (1%) | 0% | 6.2 | 31,100 | Common Stock |
| Champions Oncology Inc | Daniel N. Mendelson | Director | Purchase of securities on an exchange or from another person at price $ 5.95 per share. | 27 Sep 2023 | 1,500 | 164,581 (1%) | 0% | 6.0 | 8,925 | Common Stock |
| Champions Oncology Inc | Daniel N. Mendelson | Director | Purchase of securities on an exchange or from another person at price $ 5.65 per share. | 26 Sep 2023 | 5,000 | 145,951 (1%) | 0% | 5.7 | 28,250 | Common Stock |
| Champions Oncology Inc | Daniel N. Mendelson | Director | Purchase of securities on an exchange or from another person at price $ 5.50 per share. | 22 Sep 2023 | 3,812 | 140,951 (1%) | 0% | 5.5 | 20,966 | Common Stock |
| Champions Oncology Inc | Daniel N. Mendelson | Director | Purchase of securities on an exchange or from another person at price $ 5.51 per share. | 21 Sep 2023 | 5,000 | 137,139 (1%) | 0% | 5.5 | 27,550 | Common Stock |
| Champions Oncology Inc | Daniel N. Mendelson | Director | Purchase of securities on an exchange or from another person at price $ 5.51 per share. | 20 Sep 2023 | 4,018 | 132,139 (1%) | 0% | 5.5 | 22,139 | Common Stock |
| Champions Oncology Inc | Daniel N. Mendelson | Director | Purchase of securities on an exchange or from another person at price $ 5.28 per share. | 19 Sep 2023 | 5,000 | 128,121 (1%) | 0% | 5.3 | 26,400 | Common Stock |
| Champions Oncology Inc | Daniel N. Mendelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2022 | 19,430 | 19,430 | - | - | Option to purchase Common Stock | |
| Champions Oncology Inc | Daniel N. Mendelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2020 | 10,000 | 10,000 | - | - | Option to purchase Common Stock |